Boundary work in the implementation of an assistive exercise product to facilitate physical activity for children with cerebral palsy

Συγγραφείς: Holmberg, Robert, Author, Lauruschkus, Katarina, Author, Tornberg, Åsa B, Author, Lund University, Other research environments, CIRCE: Centre for Interdisciplinary Research on Cancer and Equity in Women, Lunds universitet, Andra forskningsmiljöer, CIRCE: Centrum för tvärvetenskaplig forskning om cancer och jämlikhet hos kvinnor, Originator, Lund University, Faculty of Engineering, LTH, Other operations, LTH, Metalund, Lunds universitet, Lunds Tekniska Högskola, Annan verksamhet, LTH, Metalund, Originator, Lund University, Faculty of Social Sciences, Departments of Administrative, Economic and Social Sciences, Department of Psychology, Lunds universitet, Samhällsvetenskapliga fakulteten, Samhällsvetenskapliga institutioner och centrumbildningar, Institutionen för psykologi, Originator, Lund University, Faculty of Medicine, Department of Health Sciences, Rehabilitation and Sustainable Health, Lunds universitet, Medicinska fakulteten, Institutionen för hälsovetenskaper, Rehabilitering och hållbar hälsa, Originator, Lund University, Faculty of Medicine, Department of Health Sciences, Care in high technological environments, Lunds universitet, Medicinska fakulteten, Institutionen för hälsovetenskaper, Vård i högteknologisk miljö, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator

Συνεισφορές: Holmberg, Robert, Author, Lauruschkus, Katarina, Author, Tornberg, Åsa B, Author, Lund University, Other research environments, CIRCE: Centre for Interdisciplinary Research on Cancer and Equity in Women, Lunds universitet, Andra forskningsmiljöer, CIRCE: Centrum för tvärvetenskaplig forskning om cancer och jämlikhet hos kvinnor, Originator, Lund University, Faculty of Engineering, LTH, Other operations, LTH, Metalund, Lunds universitet, Lunds Tekniska Högskola, Annan verksamhet, LTH, Metalund, Originator, Lund University, Faculty of Social Sciences, Departments of Administrative, Economic and Social Sciences, Department of Psychology, Lunds universitet, Samhällsvetenskapliga fakulteten, Samhällsvetenskapliga institutioner och centrumbildningar, Institutionen för psykologi, Originator, Lund University, Faculty of Medicine, Department of Health Sciences, Rehabilitation and Sustainable Health, Lunds universitet, Medicinska fakulteten, Institutionen för hälsovetenskaper, Rehabilitering och hållbar hälsa, Originator, Lund University, Faculty of Medicine, Department of Health Sciences, Care in high technological environments, Lunds universitet, Medicinska fakulteten, Institutionen för hälsovetenskaper, Vård i högteknologisk miljö, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator

Πηγή: Disability and rehabilitation. Assistive technology. :1-15

Θεματικοί όροι: Medical and Health Sciences, Health Sciences, Occupational Therapy, Medicin och hälsovetenskap, Hälsovetenskap, Arbetsterapi, Rehabilitation Medicine, Rehabiliteringsmedicin

Σύνδεσμος πρόσβασης: https://doi.org/10.1080/17483107.2026.2689113

Barriers and facilitators to implementing an online psychological intervention for adolescent and young adult cancer survivors in a community setting

Συγγραφείς: Irestorm, Elin, Author, Wakefield, Claire E, Author, Houweling, Rachel, Author, Hetherington, Kate, Author, McGill, Brittany C, Author, McDonald, Fiona E J, Author, Cohn, Richard J, Author, Sansom-Daly, Ursula M, Author, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Paediatrics (Lund), Childhood Cancer Research Unit, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Pediatrik, Lund, Childhood Cancer Research Unit, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Paediatrics (Lund), Pediatric Oncology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Pediatrik, Lund, Pediatrisk onkologi, Originator

Συνεισφορές: Irestorm, Elin, Author, Wakefield, Claire E, Author, Houweling, Rachel, Author, Hetherington, Kate, Author, McGill, Brittany C, Author, McDonald, Fiona E J, Author, Cohn, Richard J, Author, Sansom-Daly, Ursula M, Author, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Paediatrics (Lund), Childhood Cancer Research Unit, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Pediatrik, Lund, Childhood Cancer Research Unit, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Paediatrics (Lund), Pediatric Oncology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Pediatrik, Lund, Pediatrisk onkologi, Originator

Πηγή: Supportive Care in Cancer. 34(7):1-11

Θεματικοί όροι: Social Sciences, Psychology, Applied Psychology (including Clinical Psychology, Psychotherapy), Samhällsvetenskap, Psykologi, Tillämpad psykologi (Här ingår: Klinisk psykologi, psykoterapi)

Σύνδεσμος πρόσβασης: https://doi.org/10.1007/s00520-026-10867-9

NeoCircle: pre- and post-operative circulating tumor DNA dynamics predicts survival in neoadjuvant-treated early breast cancer

Συγγραφείς: George, Anthony M, Author, Chen, Yilun, Author, Gladchuk, Sergii, Author, Alcaide, Miguel, Author, Dalal, Hina, Author, Meng, Pei, Author, Brueffer, Christian, Author, Saghir, Hani, Author, Kimbung, Siker, Author, Aaltonen, Kristina, Author, Oton, Lucia, Author, Rushton, Christopher, Author, Birkeälv, Sofia, Author, Jönsson, Mats, Author, Zackrisson, Sophia, Author, Skarping, Ida, Author, Förnvik, Daniel, Author, Zander, Lina, Author, Honeth, Gabriella, Author, Woodhouse, Samuel, Author, Howarth, Karen, Author, Borg, Åke, Author, Ehinger, Anna, Author, Malmberg, Martin, Author, Rydén, Lisa, Author, Loman, Niklas, Author, Saal, Lao H, Author, Lund University, Other research environments, CIRCE: Centre for Interdisciplinary Research on Cancer and Equity in Women, Lunds universitet, Andra forskningsmiljöer, CIRCE: Centrum för tvärvetenskaplig forskning om cancer och jämlikhet hos kvinnor, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Transl oncogenomics, Translational Oncogenomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Transl onkogenomik, Translational Oncogenomics, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/ovarian cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/ovarialcancer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Molecular Pediatric Oncology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Molekylär barnonkologi, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Breast/lung cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Bröst/lungcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/lungcancer, Research Group Lung Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/lungcancer, Forskningsgrupp Lungcancer, Originator, Lund University, Faculty of Engineering, LTH, Other operations, LTH, Lund Laser Centre, LLC, Lunds universitet, Lunds Tekniska Högskola, Annan verksamhet, LTH, Lunds lasercentrum, LLC, Originator, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Light and Materials, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Ljus och material, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Photon Science and Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Avancerade ljuskällor, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Radiology Diagnostics, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Diagnostisk radiologi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast cancer treatment, The Liquid Biopsy and Tumor Progression in Breast Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancerbehandling, The Liquid Biopsy och Tumörprogression i Bröstcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer, Breast cancer prevention & intervention, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer, Bröstcancer - prevention & intervention, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Medical Radiation Physics, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Medicinsk strålningsfysik, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, Molecular therapeutics in breast cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, Molekylära behandlingsstrategier vid bröstcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, BRCA-lab, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, BRCA-lab, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, Familial Breast Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, Familjär bröstcancer, Originator, Lund University, Other research environments, Create Health, Lunds universitet, Andra forskningsmiljöer, CREATE Health, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Pathology, Lund, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Patologi, Lund, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Surgery (Lund), Breast Cancer Surgery, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Kirurgi, Lund, Bröstcancerkirurgi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Surgery (Lund), Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Kirurgi, Lund, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Transl oncogenomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Transl onkogenomik, Originator

Συνεισφορές: George, Anthony M, Author, Chen, Yilun, Author, Gladchuk, Sergii, Author, Alcaide, Miguel, Author, Dalal, Hina, Author, Meng, Pei, Author, Brueffer, Christian, Author, Saghir, Hani, Author, Kimbung, Siker, Author, Aaltonen, Kristina, Author, Oton, Lucia, Author, Rushton, Christopher, Author, Birkeälv, Sofia, Author, Jönsson, Mats, Author, Zackrisson, Sophia, Author, Skarping, Ida, Author, Förnvik, Daniel, Author, Zander, Lina, Author, Honeth, Gabriella, Author, Woodhouse, Samuel, Author, Howarth, Karen, Author, Borg, Åke, Author, Ehinger, Anna, Author, Malmberg, Martin, Author, Rydén, Lisa, Author, Loman, Niklas, Author, Saal, Lao H, Author, Lund University, Other research environments, CIRCE: Centre for Interdisciplinary Research on Cancer and Equity in Women, Lunds universitet, Andra forskningsmiljöer, CIRCE: Centrum för tvärvetenskaplig forskning om cancer och jämlikhet hos kvinnor, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Transl oncogenomics, Translational Oncogenomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Transl onkogenomik, Translational Oncogenomics, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/ovarian cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/ovarialcancer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Molecular Pediatric Oncology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Molekylär barnonkologi, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Breast/lung cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Bröst/lungcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/lungcancer, Research Group Lung Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/lungcancer, Forskningsgrupp Lungcancer, Originator, Lund University, Faculty of Engineering, LTH, Other operations, LTH, Lund Laser Centre, LLC, Lunds universitet, Lunds Tekniska Högskola, Annan verksamhet, LTH, Lunds lasercentrum, LLC, Originator, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Light and Materials, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Ljus och material, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Photon Science and Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Avancerade ljuskällor, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Radiology Diagnostics, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Diagnostisk radiologi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast cancer treatment, The Liquid Biopsy and Tumor Progression in Breast Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancerbehandling, The Liquid Biopsy och Tumörprogression i Bröstcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer, Breast cancer prevention & intervention, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer, Bröstcancer - prevention & intervention, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Medical Radiation Physics, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Medicinsk strålningsfysik, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, Molecular therapeutics in breast cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, Molekylära behandlingsstrategier vid bröstcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, BRCA-lab, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, BRCA-lab, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, Familial Breast Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, Familjär bröstcancer, Originator, Lund University, Other research environments, Create Health, Lunds universitet, Andra forskningsmiljöer, CREATE Health, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Pathology, Lund, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Patologi, Lund, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Surgery (Lund), Breast Cancer Surgery, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Kirurgi, Lund, Bröstcancerkirurgi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Surgery (Lund), Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Kirurgi, Lund, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Transl oncogenomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Transl onkogenomik, Originator

Πηγή: EMBO Molecular Medicine. :1-18

Θεματικοί όροι: Medical and Health Sciences, Clinical Medicine, Cancer and Oncology, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Basic Medicine, Cell and Molecular Biology, Medicinska och farmaceutiska grundvetenskaper, Cell- och molekylärbiologi

Σύνδεσμος πρόσβασης: https://doi.org/10.1038/s44321-026-00447-z

Paucity of type 2 cytokines and atypical IL-5 receptor alpha patterns during established eosinophilic inflammation in seasonal allergic rhinitis

Συγγραφείς: Nordström, Franziska U, Author, Sakellariou, Christina, Author, Lindö, Caroline, Author, Siddhuraj, Premkumar, Author, Jönsson, Jimmie, Author, Ahlgren, Johan, Author, Sandén, Caroline, Author, Lindstedt, Malin, Author, Greiff, Lennart, Author, Erjefält, Jonas S, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section IV, Otorhinolaryngology (Lund), Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion IV, Öron-, näs- och halssjukdomar, Lund, Originator, Lund University, Faculty of Engineering, LTH, Departments at LTH, Department of Immunotechnology, Lunds universitet, Lunds Tekniska Högskola, Institutioner vid LTH, Institutionen för immunteknologi, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Engineering Health, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Teknik för hälsa, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Experimental Medical Science, Airway Inflammation and Immunology, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Luftvägsinflammation, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Radiation therapy, Head and Neck Cancer Research Group, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Strålterapi, Huvud- och halscancergruppen, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Infect@LU, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Infect@LU, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Thoracic Surgery, DCD transplantation of lungs, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Thoraxkirurgi, DCD transplantation av lungor, Originator

Συνεισφορές: Nordström, Franziska U, Author, Sakellariou, Christina, Author, Lindö, Caroline, Author, Siddhuraj, Premkumar, Author, Jönsson, Jimmie, Author, Ahlgren, Johan, Author, Sandén, Caroline, Author, Lindstedt, Malin, Author, Greiff, Lennart, Author, Erjefält, Jonas S, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section IV, Otorhinolaryngology (Lund), Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion IV, Öron-, näs- och halssjukdomar, Lund, Originator, Lund University, Faculty of Engineering, LTH, Departments at LTH, Department of Immunotechnology, Lunds universitet, Lunds Tekniska Högskola, Institutioner vid LTH, Institutionen för immunteknologi, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Engineering Health, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Teknik för hälsa, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Experimental Medical Science, Airway Inflammation and Immunology, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Luftvägsinflammation, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Radiation therapy, Head and Neck Cancer Research Group, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Strålterapi, Huvud- och halscancergruppen, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Infect@LU, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Infect@LU, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Thoracic Surgery, DCD transplantation of lungs, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Thoraxkirurgi, DCD transplantation av lungor, Originator

Πηγή: Acta Oto-Laryngologica. :1-13

Θεματικοί όροι: Medical and Health Sciences, Clinical Medicine, Oto-rhino-laryngology, Medicin och hälsovetenskap, Klinisk medicin, Oto-rhino-laryngologi, Respiratory Medicine and Allergy, Lungmedicin och allergi

Σύνδεσμος πρόσβασης: https://doi.org/10.1080/00016489.2026.2670715

Transcriptomic Subgroups in Soft Tissue Tumors Correlate with Morphologic Subtype, Genomic Features, and Outcome

Συγγραφείς: Hofvander, Jakob, Author, Köster, Jan, Author, Sydow, Saskia, Author, Piccinelli, Paul, Author, Vult Von Steyern, Fredrik, Author, Tsagkozis, Panagiotis, Author, Hesla, Asle, Author, Magnusson, Linda, Author, Nilsson, Jenny, Author, Mertens, Fredrik, Author, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, The genetics of soft tissue tumors, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Genetiska avvikelser i mjukdelstumörer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Genetic chaos in aggressive cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Komplexa kromosomförändringar i cancer, Originator

Συνεισφορές: Hofvander, Jakob, Author, Köster, Jan, Author, Sydow, Saskia, Author, Piccinelli, Paul, Author, Vult Von Steyern, Fredrik, Author, Tsagkozis, Panagiotis, Author, Hesla, Asle, Author, Magnusson, Linda, Author, Nilsson, Jenny, Author, Mertens, Fredrik, Author, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, The genetics of soft tissue tumors, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Genetiska avvikelser i mjukdelstumörer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Genetic chaos in aggressive cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Komplexa kromosomförändringar i cancer, Originator

Πηγή: Clinical Cancer Research. 32(9):1825-1834

Θεματικοί όροι: Medical and Health Sciences, Basic Medicine, Medical Genetics and Genomics (including Gene Therapy), Medicin och hälsovetenskap, Medicinska och farmaceutiska grundvetenskaper, Medicinsk genetik och genomik (Här ingår: Genterapi), Cell and Molecular Biology, Cell- och molekylärbiologi

Σύνδεσμος πρόσβασης: https://doi.org/10.1158/1078-0432.CCR-25-3740

The ALLAN trial: impact of early home-based palliative care on emergency care and hospitalisation in advanced gastrointestinal cancer patients

Συγγραφείς: Bojesson, Anders, Author, Brun, Eva, Author, Eberhard, Jakob, Author, Segerlantz, Mikael, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Medical oncology, Palliative Oncology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Medicinsk onkologi, Palliativ onkologi, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Radiation therapy, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Strålterapi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Radiation therapy, Head and Neck Cancer Research Group, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Strålterapi, Huvud- och halscancergruppen, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Therapeutic pathology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Terapeutisk patologi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Respiratory Medicine, Allergology, and Palliative Medicine, The Institute for Palliative Care, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Lungmedicin, allergologi och palliativ medicin, Palliativt Utvecklingscentrum, Originator

Συνεισφορές: Bojesson, Anders, Author, Brun, Eva, Author, Eberhard, Jakob, Author, Segerlantz, Mikael, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Medical oncology, Palliative Oncology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Medicinsk onkologi, Palliativ onkologi, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Radiation therapy, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Strålterapi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Radiation therapy, Head and Neck Cancer Research Group, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Strålterapi, Huvud- och halscancergruppen, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Therapeutic pathology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Terapeutisk patologi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Respiratory Medicine, Allergology, and Palliative Medicine, The Institute for Palliative Care, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Lungmedicin, allergologi och palliativ medicin, Palliativt Utvecklingscentrum, Originator

Πηγή: British Journal of Cancer. :1-7

Θεματικοί όροι: Medical and Health Sciences, Health Sciences, Palliative Medicine and Palliative Care, Medicin och hälsovetenskap, Hälsovetenskap, Palliativ medicin och palliativ vård

Σύνδεσμος πρόσβασης: https://doi.org/10.1038/s41416-026-03444-8

Redefining Cytotechnologist Practice in Sweden: National Survey on Workload, Expanded Roles, and Future Competency Needs

Συγγραφείς: Basic, Vladimir, Author, Stacke, Karin A, Author, Rexaj, Genta, Author, Kirova, Nadi, Author, Sanchez Benito, Maria, Author, Englund, Belinda, Author, Omholt, Katarina, Author, Mansour, Mohammed S I, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/ovarian cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/ovarialcancer, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Pathology, Lund, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Patologi, Lund, Originator

Συνεισφορές: Basic, Vladimir, Author, Stacke, Karin A, Author, Rexaj, Genta, Author, Kirova, Nadi, Author, Sanchez Benito, Maria, Author, Englund, Belinda, Author, Omholt, Katarina, Author, Mansour, Mohammed S I, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/ovarian cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/ovarialcancer, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Pathology, Lund, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Patologi, Lund, Originator

Πηγή: Acta Cytologica. :1-13

Θεματικοί όροι: Medical and Health Sciences, Health Sciences, Health Care Service and Management, Health Policy and Services and Health Economy, Medicin och hälsovetenskap, Hälsovetenskap, Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi

Σύνδεσμος πρόσβασης: https://doi.org/10.1159/000551322

Chinese expert consensus on standardized management of PI3K/AKT inhibitor-associated hyperglycemia in breast cancer (2026 edition)

Συγγραφείς: Clinical Cancer Research Evaluation Committee of Chinese Medical Education Association, Cancer Drug Clinical Research Committee of Shanghai Anti-Cancer Association, Breast Cancer Study Group Along the Yangtze River

Πηγή: Zhongguo aizheng zazhi, Vol 36, Pp 412-424 (2026)

Θεματικοί όροι: Breast cancer, PI3K/AKT inhibitors, Hyperglycemia, Management, Expert consensus, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

Περιγραφή αρχείου: electronic resource

Relation: http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2026.04.010; https://doaj.org/toc/1007-3639

Σύνδεσμος πρόσβασης: https://doaj.org/article/debd3a6051ef4080a392978c2235cd5e

Vitamin K-dependent proteins in patients undergoing head and neck free flap surgery - a prospective observational study

Συγγραφείς: Persson, Karolina, Author, Nilsson, Caroline Ulfsdotter, Author, Sjövall, Johanna, Author, Walther Sturesson, Louise, Author, Schurgers, Leon, Author, Kander, Thomas, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Anesthesiology and Intensive Care, Clinical Research in Anaesthesia and Intensive Care Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Anestesiologi och intensivvård, Klinisk forskning inom anestesi och intensivvårdsmedicin, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Radiation therapy, Head and Neck Cancer Research Group, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Strålterapi, Huvud- och halscancergruppen, Originator

Συνεισφορές: Persson, Karolina, Author, Nilsson, Caroline Ulfsdotter, Author, Sjövall, Johanna, Author, Walther Sturesson, Louise, Author, Schurgers, Leon, Author, Kander, Thomas, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Anesthesiology and Intensive Care, Clinical Research in Anaesthesia and Intensive Care Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Anestesiologi och intensivvård, Klinisk forskning inom anestesi och intensivvårdsmedicin, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Radiation therapy, Head and Neck Cancer Research Group, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Strålterapi, Huvud- och halscancergruppen, Originator

Πηγή: Scandinavian Journal of Clinical and Laboratory Investigation. :1-9

Θεματικοί όροι: Medical and Health Sciences, Clinical Medicine, Surgery, Medicin och hälsovetenskap, Klinisk medicin, Kirurgi, Clinical Laboratory Medicine, Klinisk laboratoriemedicin

Σύνδεσμος πρόσβασης: https://doi.org/10.1080/00365513.2026.2694050

Size-based sorting of cancer cells reveals functional heterogeneity among subpopulations

Συγγραφείς: Yilmaz, Esra, Author, Fan, Zhimeng, Author, Beech, Jason P., Author, Swaminathan, Vinay S., Author, Tegenfeldt, Jonas O., Author, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Light and Materials, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Ljus och material, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Engineering Health, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Teknik för hälsa, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Nanoscience and Semiconductor Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Nanovetenskap och halvledarteknologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), NanoLund: Centre for Nanoscience, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), NanoLund: Centre for Nanoscience, Originator, Lund University, Faculty of Science, Department of Physics, Solid State Physics, Lunds universitet, Naturvetenskapliga fakulteten, Fysiska institutionen, Fasta tillståndets fysik, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Cell mechanobiology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Cellmekanobiologi, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Centre for Research Infrastructure in Health and Life Sciences (CRI), WCMM-Wallenberg Centre for Molecular Medicine, Lunds universitet, Medicinska fakulteten, Centre for Research Infrastructure in Health and Life Sciences (CRI), WCMM- Wallenberg center för molekylär medicinsk forskning, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Photon Science and Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Avancerade ljuskällor, Originator

Συνεισφορές: Yilmaz, Esra, Author, Fan, Zhimeng, Author, Beech, Jason P., Author, Swaminathan, Vinay S., Author, Tegenfeldt, Jonas O., Author, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Light and Materials, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Ljus och material, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Engineering Health, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Teknik för hälsa, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Nanoscience and Semiconductor Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Nanovetenskap och halvledarteknologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), NanoLund: Centre for Nanoscience, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), NanoLund: Centre for Nanoscience, Originator, Lund University, Faculty of Science, Department of Physics, Solid State Physics, Lunds universitet, Naturvetenskapliga fakulteten, Fysiska institutionen, Fasta tillståndets fysik, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Cell mechanobiology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Cellmekanobiologi, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Centre for Research Infrastructure in Health and Life Sciences (CRI), WCMM-Wallenberg Centre for Molecular Medicine, Lunds universitet, Medicinska fakulteten, Centre for Research Infrastructure in Health and Life Sciences (CRI), WCMM- Wallenberg center för molekylär medicinsk forskning, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Photon Science and Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Avancerade ljuskällor, Originator

Πηγή: Lab on a Chip. 26(11):3459-3472

Θεματικοί όροι: Natural Sciences, Physical Sciences, Condensed Matter Physics (including Material Physics, Nano Physics), Naturvetenskap, Fysik, Den kondenserade materiens fysik (Här ingår: Materialfysik, nanofysik), Medical and Health Sciences, Clinical Medicine, Cancer and Oncology, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi

Σύνδεσμος πρόσβασης: https://doi.org/10.1039/d5lc01042j

Guideline for the diagnosis and comprehensive treatment of colorectal cancer liver metastases (2025 edition)

Συγγραφείς: College of Surgeons, Chinese Medical Doctor Association Chinese, Surgery Group, Chinese Society of Surgery, Chinese Medical Association Gastrointestinal, Surgery Group, Chinese Society of Surgery, Chinese Medical Association Colorectal, Cancer Professional Committee, Chinese Anti-Cancer Association Colorectal, Cancer Professional Committee, Chinese Medical Doctor Association Colorectal, Cancer Expert Committee, Chinese Society of Clinical Oncology Colorectal, Surgeons Committee, Chinese Congress of Surgeons, Chinese Medical Doctor Association Colorectal, Metastasis Committee, Anorectal Branch of Chinese Medical Doctor Association Tumor, of Colorectal Oncology, Chinese Society of Oncology, Chinese Medical Association Section, Tumor Therapeutics Branch, China International Exchange and Promotive Association for Medical and Health Care Metastatic, Disease Branch, China International Exchange and Promotive Association for Medical and Health Care Colorectal

Πηγή: Zhongguo Linchuang Yixue, Vol 33, Iss 1, Pp 160-190 (2026)

Θεματικοί όροι: colorectal cancer, colorectal cancer liver metastasis, diagnosis and treatment guideline, Medicine

Περιγραφή αρχείου: electronic resource

Relation: https://doaj.org/toc/1008-6358

Σύνδεσμος πρόσβασης: https://doaj.org/article/cb4e2e7dfda6488ca0235854ffe00c7d

Tumor microenvironment transcriptional activity enables robust stratification of chemotherapy response in triple-negative breast cancer

Συγγραφείς: Dai, Yaoyi, Author, Pan, Xiaoxi, Author, Guo, Shuai, Author, Ji, Shuangxi, Author, Cao, Shaolong, Author, Montierth, Matthew D, Author, Jiang, Yujie, Author, Chang, Jeffrey T, Author, Shi, Leming, Author, Shalapour, Shabnam, Author, Echeverria, Gloria V, Author, Yates, Lucy, Author, Staaf, Johan, Author, Lim, Bora, Author, Yuan, Yinyin, Author, Wang, Wenyi, Author, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Breast/lung cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Bröst/lungcancer, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/lungcancer, Research Group Lung Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/lungcancer, Forskningsgrupp Lungcancer, Originator

Συνεισφορές: Dai, Yaoyi, Author, Pan, Xiaoxi, Author, Guo, Shuai, Author, Ji, Shuangxi, Author, Cao, Shaolong, Author, Montierth, Matthew D, Author, Jiang, Yujie, Author, Chang, Jeffrey T, Author, Shi, Leming, Author, Shalapour, Shabnam, Author, Echeverria, Gloria V, Author, Yates, Lucy, Author, Staaf, Johan, Author, Lim, Bora, Author, Yuan, Yinyin, Author, Wang, Wenyi, Author, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Breast/lung cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Bröst/lungcancer, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/lungcancer, Research Group Lung Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/lungcancer, Forskningsgrupp Lungcancer, Originator

Πηγή: Cell Reports Medicine. 7(2):1-15

Θεματικοί όροι: Medical and Health Sciences, Basic Medicine, Cell and Molecular Biology, Medicin och hälsovetenskap, Medicinska och farmaceutiska grundvetenskaper, Cell- och molekylärbiologi, Clinical Medicine, Cancer and Oncology, Klinisk medicin, Cancer och onkologi

Σύνδεσμος πρόσβασης: https://doi.org/10.1016/j.xcrm.2026.102610

Multiomics assessment of lung adenocarcinoma subtypes defined through tumor purity-adjusted DNA methylation

Συγγραφείς: Nacer, Deborah F, Author, Arbajian, Elsa, Author, Veerla, Srinivas, Author, Aine, Mattias, Author, Jönsson, Mats, Author, Rosengren, Frida, Author, Karlsson, Anna, Author, Salomonsson, Annette, Author, Isaksson, Sofi, Author, Planck, Maria, Author, Staaf, Johan, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/lungcancer, Research Group Lung Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/lungcancer, Forskningsgrupp Lungcancer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Breast/lung cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Bröst/lungcancer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/lungcancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/lungcancer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, The genetics of soft tissue tumors, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Genetiska avvikelser i mjukdelstumörer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/ovarian cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/ovarialcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/ovarian cancer, Breast and Ovarian Cancer Genomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/ovarialcancer, Bröst- och ovarialcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Molecular Hematology (DMH), Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för molekylär hematologi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Respiratory Medicine, Allergology, and Palliative Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Lungmedicin, allergologi och palliativ medicin, Originator

Συνεισφορές: Nacer, Deborah F, Author, Arbajian, Elsa, Author, Veerla, Srinivas, Author, Aine, Mattias, Author, Jönsson, Mats, Author, Rosengren, Frida, Author, Karlsson, Anna, Author, Salomonsson, Annette, Author, Isaksson, Sofi, Author, Planck, Maria, Author, Staaf, Johan, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/lungcancer, Research Group Lung Cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/lungcancer, Forskningsgrupp Lungcancer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Breast/lung cancer, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Bröst/lungcancer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/lungcancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/lungcancer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, The genetics of soft tissue tumors, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Genetiska avvikelser i mjukdelstumörer, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Clinical Genetics, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för klinisk genetik, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/ovarian cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/ovarialcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breast/ovarian cancer, Breast and Ovarian Cancer Genomics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröst/ovarialcancer, Bröst- och ovarialcancer, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Breastcancer-genetics, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Bröstcancer-genetik, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Molecular Hematology (DMH), Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för molekylär hematologi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section II, Respiratory Medicine, Allergology, and Palliative Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion II, Lungmedicin, allergologi och palliativ medicin, Originator

Πηγή: Genome Medicine. 18:1-21

Θεματικοί όροι: Medical and Health Sciences, Clinical Medicine, Cancer and Oncology, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi, Basic Medicine, Medical Epigenetics and Epigenomics, Medicinska och farmaceutiska grundvetenskaper, Medicinsk epigenetik och epigenomik

Σύνδεσμος πρόσβασης: https://doi.org/10.1186/s13073-026-01609-x

RAB3GAP2 is a regulator of skeletal muscle endothelial cell proliferation and associated with capillary-to-fiber ratio

Συγγραφείς: Ström, Kristoffer, Author, Oskolkov, Nikolay, Author, Karaderi, Tugce, Author, Kalamajski, Sebastian, Author, Mir, Bilal A, Author, Ekström, Ola, Author, Miyamoto-Mikami, Eri, Author, Ladenvall, Claes, Author, Kakulidis, Ellen, Author, Reid, Steven, Author, Dutius Andersson, Anna-Maria, Author, Kryvokhyzha, Dmytro, Author, Zhang, Enming, Author, Fadista, Joao, Author, Thangam, Manonanthini, Author, Iemitsu, Motoyuki, Author, Semenova, Ekaterina A, Author, Larin, Andrey K, Author, Sultanov, Rinat I, Author, Babalyan, Konstantin A, Author, Zhelankin, Andrey V, Author, Kulemin, Nikolay A, Author, Generozov, Edward V, Author, Hultström, Michael, Author, Frithiof, Robert, Author, Zeberg, Hugo, Author, Lipcsey, Miklos, Author, Larsson, Anders, Author, Mahajan, Anubha, Author, Ahlqvist, Emma, Author, Prasad, Rashmi B, Author, Prüfer, Kay, Author, Sabater-Lleal, Maria, Author, Smith, Nicholas L, Author, Dehghan, Abbas, Author, Lind, Lars, Author, McGawley, Kerry, Author, Morris, Andrew P, Author, Andersson, Johan P A, Author, Lehtovirta, Mikko, Author, Szczerbiński, Łukasz, Author, Kretowski, Adam, Author, Fuku, Noriyuki, Author, Holmberg, Hans-Christer, Author, Gomez, Maria F, Author, Eriksson, Karl-Fredrik, Author, Pietras, Kristian, Author, Lindgren, Cecilia M, Author, Franks, Paul W, Author, Hansson, Ola, Author, CHARGE Hemostasis Working Group, Author, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EXODIAB: Excellence of Diabetes Research in Sweden, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EXODIAB: Excellence of Diabetes Research in Sweden, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Translational Muscle Research, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Translationell muskelforskning, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Genetic and Molecular Epidemiology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Genetisk och molekylär epidemiologi, Originator, Lund University, Faculty of Medicine, Department of Experimental Medical Science, Diabetes and Brain Function, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Diabetes och hjärnans funktion, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Experimental oncology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Experimentell onkologi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Diabetic Complications, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Diabetiska komplikationer, Originator, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Light and Materials, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Ljus och material, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Nanoscience and Semiconductor Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Nanovetenskap och halvledarteknologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), NanoLund: Centre for Nanoscience, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), NanoLund: Centre for Nanoscience, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Diabetes - Islet Patophysiology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Diabetes - öpatofysiologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Genetics and Diabetes, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Genetik och diabetes, Originator, Lund University, Faculty of Medicine, Department of Experimental Medical Science, Integrative Physiology, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Integrativ fysiologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), eSSENCE: The e-Science Collaboration, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), eSSENCE: The e-Science Collaboration, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Originator, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Proactive Ageing, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Proaktivt åldrande, Originator

Συνεισφορές: Ström, Kristoffer, Author, Oskolkov, Nikolay, Author, Karaderi, Tugce, Author, Kalamajski, Sebastian, Author, Mir, Bilal A, Author, Ekström, Ola, Author, Miyamoto-Mikami, Eri, Author, Ladenvall, Claes, Author, Kakulidis, Ellen, Author, Reid, Steven, Author, Dutius Andersson, Anna-Maria, Author, Kryvokhyzha, Dmytro, Author, Zhang, Enming, Author, Fadista, Joao, Author, Thangam, Manonanthini, Author, Iemitsu, Motoyuki, Author, Semenova, Ekaterina A, Author, Larin, Andrey K, Author, Sultanov, Rinat I, Author, Babalyan, Konstantin A, Author, Zhelankin, Andrey V, Author, Kulemin, Nikolay A, Author, Generozov, Edward V, Author, Hultström, Michael, Author, Frithiof, Robert, Author, Zeberg, Hugo, Author, Lipcsey, Miklos, Author, Larsson, Anders, Author, Mahajan, Anubha, Author, Ahlqvist, Emma, Author, Prasad, Rashmi B, Author, Prüfer, Kay, Author, Sabater-Lleal, Maria, Author, Smith, Nicholas L, Author, Dehghan, Abbas, Author, Lind, Lars, Author, McGawley, Kerry, Author, Morris, Andrew P, Author, Andersson, Johan P A, Author, Lehtovirta, Mikko, Author, Szczerbiński, Łukasz, Author, Kretowski, Adam, Author, Fuku, Noriyuki, Author, Holmberg, Hans-Christer, Author, Gomez, Maria F, Author, Eriksson, Karl-Fredrik, Author, Pietras, Kristian, Author, Lindgren, Cecilia M, Author, Franks, Paul W, Author, Hansson, Ola, Author, CHARGE Hemostasis Working Group, Author, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EXODIAB: Excellence of Diabetes Research in Sweden, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EXODIAB: Excellence of Diabetes Research in Sweden, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Translational Muscle Research, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Translationell muskelforskning, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Genetic and Molecular Epidemiology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Genetisk och molekylär epidemiologi, Originator, Lund University, Faculty of Medicine, Department of Experimental Medical Science, Diabetes and Brain Function, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Diabetes och hjärnans funktion, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Experimental oncology, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Experimentell onkologi, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Diabetic Complications, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Diabetiska komplikationer, Originator, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Light and Materials, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Ljus och material, Originator, Lund University, Faculty of Engineering, LTH, LTH Profile areas, LTH Profile Area: Nanoscience and Semiconductor Technology, Lunds universitet, Lunds Tekniska Högskola, LTH profilområden, LTH profilområde: Nanovetenskap och halvledarteknologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), NanoLund: Centre for Nanoscience, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), NanoLund: Centre for Nanoscience, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Diabetes - Islet Patophysiology, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Diabetes - öpatofysiologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Genetics and Diabetes, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Genetik och diabetes, Originator, Lund University, Faculty of Medicine, Department of Experimental Medical Science, Integrative Physiology, Lunds universitet, Medicinska fakulteten, Institutionen för experimentell medicinsk vetenskap, Integrativ fysiologi, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), eSSENCE: The e-Science Collaboration, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), eSSENCE: The e-Science Collaboration, Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Translational Cancer Research, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för translationell cancerforskning, Originator, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Proactive Ageing, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Proaktivt åldrande, Originator

Πηγή: Cell Reports. 45(2):1-25

Θεματικοί όροι: Medical and Health Sciences, Basic Medicine, Cell and Molecular Biology, Medicin och hälsovetenskap, Medicinska och farmaceutiska grundvetenskaper, Cell- och molekylärbiologi

Σύνδεσμος πρόσβασης: https://doi.org/10.1016/j.celrep.2026.116961

New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study

Συγγραφείς: Karpinski, M.J., Author, Bjartell, A., Author, Trägårdh, E., Author, Fendler, Wolfgang P., Author, PROMISE Registry Group, Author, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), eSSENCE: The e-Science Collaboration, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), eSSENCE: The e-Science Collaboration, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Urological cancer, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Urologisk cancerforskning, Malmö, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Originator, Lund University, Faculty of Medicine, Centre for Research Infrastructure in Health and Life Sciences (CRI), WCMM-Wallenberg Centre for Molecular Medicine, Lunds universitet, Medicinska fakulteten, Centre for Research Infrastructure in Health and Life Sciences (CRI), WCMM- Wallenberg center för molekylär medicinsk forskning, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Clinical Physiology and Nuclear Medicine, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Klinisk fysiologi och nuklearmedicin, Malmö, Originator

Συνεισφορές: Karpinski, M.J., Author, Bjartell, A., Author, Trägårdh, E., Author, Fendler, Wolfgang P., Author, PROMISE Registry Group, Author, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), eSSENCE: The e-Science Collaboration, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), eSSENCE: The e-Science Collaboration, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Urological cancer, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Urologisk cancerforskning, Malmö, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), EpiHealth: Epidemiology for Health, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), EpiHealth: Epidemiology for Health, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Originator, Lund University, Faculty of Medicine, Centre for Research Infrastructure in Health and Life Sciences (CRI), WCMM-Wallenberg Centre for Molecular Medicine, Lunds universitet, Medicinska fakulteten, Centre for Research Infrastructure in Health and Life Sciences (CRI), WCMM- Wallenberg center för molekylär medicinsk forskning, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Clinical Physiology and Nuclear Medicine, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Klinisk fysiologi och nuklearmedicin, Malmö, Originator

Πηγή: The Lancet Oncology. 27(4):480-490

Θεματικοί όροι: Medical and Health Sciences, Clinical Medicine, Cancer and Oncology, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi

Σύνδεσμος πρόσβασης: https://doi.org/10.1016/S1470-2045(26)00016-1

Effects of ovarian ablation or suppression on breast cancer recurrence and survival: patient-level meta-analysis of 15 000 women in 23 randomised trials.

Συγγραφείς: Early, Breast Cancer Trialists' Collaborative Group (EBCTCG). Electronic address: bc.overview@ndph.ox.ac.uk, Author, Early, Breast Cancer Trialists' Collaborative Group (EBCTCG), Author

Συνεισφορές: Early, Breast Cancer Trialists' Collaborative Group (EBCTCG). Electronic address: bc.overview@ndph.ox.ac.uk, Author, Early, Breast Cancer Trialists' Collaborative Group (EBCTCG), Author

Πηγή: LANCET. 407(10540):1699-1711

Σύνδεσμος πρόσβασης: https://ki.se/en/research/search-research-information?t=2&query=id%3A1132720

Pulmonary findings in COVID-19: radiology correlates with the histopathological post-mortem findings in patients with fatal acute disease

Συγγραφείς: Svensson, Ann Mari, Author, Szekely, Laszlo, Author, Brunnström, Hans, Author, Kistner, Anna, Author, Ortiz-Villalón, Cristian, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Pathology, Lund, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Patologi, Lund, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Pathology, Lund, Improved diagnostics and prognostics of lung cancer and metastases to the lungs, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Patologi, Lund, Förbättrad diagnostik och prognostik vid lungcancer och metastaser till lunga, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Originator

Συνεισφορές: Svensson, Ann Mari, Author, Szekely, Laszlo, Author, Brunnström, Hans, Author, Kistner, Anna, Author, Ortiz-Villalón, Cristian, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Pathology, Lund, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Patologi, Lund, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Pathology, Lund, Improved diagnostics and prognostics of lung cancer and metastases to the lungs, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Patologi, Lund, Förbättrad diagnostik och prognostik vid lungcancer och metastaser till lunga, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Originator

Πηγή: Acta Radiologica. 67(5):463-474

Θεματικοί όροι: Medical and Health Sciences, Clinical Medicine, Cardiology and Cardiovascular Disease, Medicin och hälsovetenskap, Klinisk medicin, Kardiologi och kardiovaskulära sjukdomar

Σύνδεσμος πρόσβασης: https://doi.org/10.1177/02841851261425663

Application of the International Bladder Cancer Group prediction model for recurrence-free survival on a national cohort of primary intermediate risk non-muscle invasive bladder cancer

Συγγραφείς: Mesinovic, Denis, Author, Bobjer, Johannes, Author, Hagberg, Oskar, Author, Aljabery, Firas, Author, Gårdmark, Truls, Author, Jahnson, Staffan, Author, Jerlström, Tomas, Author, Kjölhede, Henrik, Author, Malmström, Per Uno, Author, Ströck, Viveka, Author, Söderkvist, Karin, Author, Ullén, Anders, Author, Holmberg, Lars, Author, Häggström, Christel, Author, Liedberg, Fredrik, Author, Lund University, Faculty of Medicine, Department of Translational Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Urology - urothelial cancer, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Urologi - blåscancer, Malmö, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Urothelial cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Urinblåsecancer, Originator

Συνεισφορές: Mesinovic, Denis, Author, Bobjer, Johannes, Author, Hagberg, Oskar, Author, Aljabery, Firas, Author, Gårdmark, Truls, Author, Jahnson, Staffan, Author, Jerlström, Tomas, Author, Kjölhede, Henrik, Author, Malmström, Per Uno, Author, Ströck, Viveka, Author, Söderkvist, Karin, Author, Ullén, Anders, Author, Holmberg, Lars, Author, Häggström, Christel, Author, Liedberg, Fredrik, Author, Lund University, Faculty of Medicine, Department of Translational Medicine, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Urology - urothelial cancer, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Urologi - blåscancer, Malmö, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section I, Urothelial cancer, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion I, Urinblåsecancer, Originator

Πηγή: Scandinavian Journal of Urology. 61:127-130

Θεματικοί όροι: Medical and Health Sciences, Clinical Medicine, Cancer and Oncology, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi

Σύνδεσμος πρόσβασης: https://doi.org/10.2340/sju.v61.45712

Factors associated with potentially inappropriate medication use, medication underuse and overuse in older adults in the German National Cohort

Συγγραφείς: Degen, Miriam, Author, Haug, Ulrike, Author, Scholle, Oliver H.F., Author, Awuku-Larbi, Yaw, Author, Carlsson, Sigrid, Author, Ebert, Nina, Author, Harth, Volker, Author, Hauri, Anja M., Author, Heier, Margit, Author, Herrmann, Anne, Author, Leitzmann, Michael, Author, Linseisen, Jakob, Author, Meinke-Franze, Claudia, Author, Obi, Nadia, Author, Pendt, Phil, Author, Reinhold, Thomas, Author, Thorand, Barbara, Author, Brenner, Hermann, Author, Schöttker, Ben, Author, Lund University, Faculty of Medicine, Department of Translational Medicine, Urological cancer, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Urologisk cancerforskning, Malmö, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator

Συνεισφορές: Degen, Miriam, Author, Haug, Ulrike, Author, Scholle, Oliver H.F., Author, Awuku-Larbi, Yaw, Author, Carlsson, Sigrid, Author, Ebert, Nina, Author, Harth, Volker, Author, Hauri, Anja M., Author, Heier, Margit, Author, Herrmann, Anne, Author, Leitzmann, Michael, Author, Linseisen, Jakob, Author, Meinke-Franze, Claudia, Author, Obi, Nadia, Author, Pendt, Phil, Author, Reinhold, Thomas, Author, Thorand, Barbara, Author, Brenner, Hermann, Author, Schöttker, Ben, Author, Lund University, Faculty of Medicine, Department of Translational Medicine, Urological cancer, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Urologisk cancerforskning, Malmö, Originator, Lund University, Profile areas and other strong research environments, Other Strong Research Environments, LUCC: Lund University Cancer Centre, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Övriga starka forskningsmiljöer, LUCC: Lunds universitets cancercentrum, Originator

Πηγή: Journal of Internal Medicine. 299(6):754-775

Θεματικοί όροι: Medical and Health Sciences, Health Sciences, Public Health, Global Health and Social Medicine, Medicin och hälsovetenskap, Hälsovetenskap, Folkhälsovetenskap, global hälsa och socialmedicin

Σύνδεσμος πρόσβασης: https://doi.org/10.1111/joim.70097

Real-world evaluation of a population-based vaginal self-sampling program for cervical cancer prevention in Region Skåne, Sweden

Συγγραφείς: Hellsten, Caroline, Author, Forslund, Ola, Author, Borgfeldt, Christer, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Obstetrics and Gynaecology (Lund), Gynecological Cancer and Cancer prevention as well as prevention of Osteoporosis, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Obstetrik och gynekologi, Lund, Gynekologisk cancer, förebyggande av cancer och osteoporos, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Obstetrics and Gynaecology (Lund), Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Obstetrik och gynekologi, Lund, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Clinical Microbiology, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Klinisk mikrobiologi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Systems Virology, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Systemvirologi, Originator

Συνεισφορές: Hellsten, Caroline, Author, Forslund, Ola, Author, Borgfeldt, Christer, Author, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Obstetrics and Gynaecology (Lund), Gynecological Cancer and Cancer prevention as well as prevention of Osteoporosis, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Obstetrik och gynekologi, Lund, Gynekologisk cancer, förebyggande av cancer och osteoporos, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Lund, Section V, Obstetrics and Gynaecology (Lund), Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Lund, Sektion V, Obstetrik och gynekologi, Lund, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Clinical Microbiology, Malmö, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Klinisk mikrobiologi, Malmö, Originator, Lund University, Faculty of Medicine, Department of Translational Medicine, Systems Virology, Lunds universitet, Medicinska fakulteten, Institutionen för translationell medicin, Systemvirologi, Originator

Πηγή: Acta Obstetricia et Gynecologica Scandinavica. 105(6):1043-1051

Θεματικοί όροι: Medical and Health Sciences, Clinical Medicine, Cancer and Oncology, Medicin och hälsovetenskap, Klinisk medicin, Cancer och onkologi

Σύνδεσμος πρόσβασης: https://doi.org/10.1111/aogs.70206